GEN
Overvalued by 98.2% based on the discounted cash flow analysis.
Market cap | $12.98 Billion |
---|---|
Enterprise Value | $21.75 Billion |
Dividend Yield | $0.4918 (2.41%) |
Earnings per Share | $2.17 |
Beta | 1.16 |
Outstanding Shares | 636,909,965 |
Avg 30 Day Volume | 3,076,209 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 9.29 |
---|---|
PEG | -73.0 |
Price to Sales | 4.17 |
Price to Book Ratio | 6.94 |
Enterprise Value to Revenue | 5.73 |
Enterprise Value to EBIT | 19.26 |
Enterprise Value to Net Income | 15 |
Total Debt to Enterprise | 0.43 |
Debt to Equity | 3.83 |
No data
No data